🔍
Search Results - paul+zarek
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Inducing and Inhibiting T Cell Tolerance with A2a Receptor Agonists and Antagonists
C04897: Inducing and Inhibiting T Cell Tolerance with A2a Receptor Agonists and AntagonistsValue Proposition: • Therapeutic target for developing tolerance-inducing agents and tolerance-inhibiting agents for the treatment of autoimmune disease and cancer • Methods of treating an infection by enhancing the generation of antigen-specific...
Published: 3/13/2025
|
Inventor(s):
Paul Zarek
,
Charles Drake
,
Jonathan Powell
Keywords(s):
Agonists/Promoters
,
Antagonists/Inhibitors
,
Autoimmune Diseases
,
Cancers
,
Disease Indication
,
Immunotherapy
,
Infectious Diseases
,
Inflammatory Disorders
,
Non-novel
,
Predicted Novelty
,
Repurposed
,
Single
,
Small Molecules
,
Therapeutic Matter
,
Therapeutic Substance
,
Therapeutics
,
Therapy Type
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Autoimmunity
,
Clinical and Disease Specializations > Immunology
,
Clinical and Disease Specializations > Infectious Diseases
,
Clinical and Disease Specializations > Inflammation
,
Clinical and Disease Specializations > Oncology
,
Clinical and Disease Specializations > Rare Diseases
,
Technology Classifications > Therapeutic Modalities > Immunotherapies
,
Technology Classifications > Therapeutic Modalities > Small Molecules
,
Technology Classifications > Therapeutic Modalities > Targets
,
Technology Classifications > Therapeutic Modalities
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum